Breaking News
September 22, 2018 - Brigham Genomic Medicine program unravels 30 medical mysteries
September 22, 2018 - New system harnesses power of bubbles to destroy dangerous biofilms
September 22, 2018 - Inflammation plays crucial role in preventing heart attacks and strokes, study reveals
September 22, 2018 - Calorie dense, nutrient deficient meals common across the world
September 22, 2018 - Researchers develop technology to study behavior of implants without animal testing
September 22, 2018 - First gut bacteria in newborns may have lasting effect on ability to ward off chronic diseases
September 22, 2018 - Detection of BFD virus in parrots in 8 new countries raises concerns for threatened species
September 22, 2018 - Insulin treatment shows great potential against chronic bowel inflammation
September 22, 2018 - ‘Liking Gap’ Might Stand in Way of New Friendships
September 22, 2018 - Simple factors that can avoid harmful side effects in type 2 diabetes
September 22, 2018 - ALSAM Foundation invests additional $2 million for drug discovery and development projects
September 22, 2018 - Study findings may advance discussion of how to effectively curb human-wildlife conflict
September 22, 2018 - Dopamine neurons may involve in conditions ranging from Parkinson’s disease to schizophrenia
September 22, 2018 - Protein C and Protein S Tests: MedlinePlus Lab Test Information
September 22, 2018 - Obesity and diabetes—two reasons why we should be worried about the plastics that surround us
September 22, 2018 - Concern over fussy eating prompts parents to use non-responsive feeding practices
September 22, 2018 - Novel mathematical approach uncovers existence of unsuspected biological cycles
September 22, 2018 - Cancer Research UK invests £14 million to transform London into cancer biotherapeutics hub
September 22, 2018 - Scientists predict how well the body will fight lung cancer by analyzing immune cell shapes
September 22, 2018 - New outbreak of rare eye disease identified in contact lens wearers
September 22, 2018 - Iterum Initiates SURE 2 and SURE 3 Phase 3 Clinical Trials of IV and Oral Sulopenem in Complicated Urinary Tract and Complicated Intra-abdominal Infections
September 22, 2018 - Research finds divide in dental health accessibility between city and regional areas
September 22, 2018 - Premature babies show better brain development when fed breast milk, finds study
September 22, 2018 - Novel system uses AI to detect abnormalities in fetal hearts
September 22, 2018 - UNC scientists reveal new approach to prevent obesity and diabetes
September 22, 2018 - CWRU receives NIH grant to learn how non-coding genes contribute to spread of colorectal cancer
September 22, 2018 - Scientists better understand influenza virus and how it spreads
September 22, 2018 - Scientists to focus on length of time when a person is alive and healthy
September 22, 2018 - Study shows positive financial impacts of Medicaid expansion for low-income Michigan residents
September 22, 2018 - Innovative approach for developing vaccine against most prevalent human malaria parasite
September 22, 2018 - Survey estimates caregiving costs for family members
September 22, 2018 - Inhibiting NF-kB improves heart function in a mouse model of Duchenne muscular dystrophy
September 22, 2018 - Introducing new EMR system may affect several aspects of clinic workflow
September 22, 2018 - Study finds why some human genes are more popular with biomedical researchers
September 22, 2018 - Finding epigenetic signature appears to predict inflammation risk in serious type of IBD
September 22, 2018 - Researchers develop light-based technique to measure very weak magnetic fields
September 22, 2018 - UAB researchers study dysfunction of the immune system associated with NSAID carprofen
September 22, 2018 - QIAGEN and DiaSorin launch automated, CE-marked workflow for high-throughput TB screening
September 22, 2018 - EFS checklist provides user-friendly tool for evaluating feeding skills in preterm infants
September 22, 2018 - Family history in blacks, Latinos associated with higher risk of AFib
September 22, 2018 - Researchers identify new genetic disorder in a human patient
September 22, 2018 - Cardiac MR With Contrast Feasible in Developing World
September 22, 2018 - Daily low-dose aspirin doesn’t reduce heart-attack risk in healthy people
September 21, 2018 - Children with asthma found to be disadvantaged in education and future occupation
September 21, 2018 - Interaction of chemical slurry and ancient shale in fracking wastewater causes radioactivity
September 21, 2018 - Scientists use mice to study transmission of Lyme disease bacteria by infected ticks
September 21, 2018 - Researchers find that sample size is key factor determining accuracy of study results
September 21, 2018 - Study shows how the drive to eat overpowers the brain’s signal to stop
September 21, 2018 - 30 Million Americans Now Have Diabetes
September 21, 2018 - Thousands of breast cancer gene variants engineered and analyzed
September 21, 2018 - The current fellowship interview process is cumbersome — Stanford researchers have a better idea
September 21, 2018 - Progenitor cells for human bone and cartilage have been identified
September 21, 2018 - Study reveals new therapeutic target for pediatric tumor-associated intractable epilepsy
September 21, 2018 - SLU’s College professor receives NIH grant to develop I-TEST project
September 21, 2018 - DermTech completes enrollment in clinical study to assess DNA damage and reversal
September 21, 2018 - Grieving patients treated with talk therapy have lower risk of suicide and psychiatric illness
September 21, 2018 - NIH and FDA call for eliminating involvement of RAC in human gene therapy experiments
September 21, 2018 - New system uses algorithm to convert 2D videos into 3D printed ‘motion sculptures’
September 21, 2018 - Sea squirt model reveals key molecules in dopaminergic neuron differentiation
September 21, 2018 - Effective management of neonatal abstinence syndrome requires coordinated ‘cascade of care’
September 21, 2018 - Refugees seek care for wounds of war
September 21, 2018 - Under the sea, in an octopus’ garden on ecstacy
September 21, 2018 - Eating foods with low nutritional quality ratings linked to cancer risk in large European cohort
September 21, 2018 - Giving kids honest information about water consumption may help them make healthy choices
September 21, 2018 - Horwitz Prize Awarded for Work on Hormones
September 21, 2018 - CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients
September 21, 2018 - Scientists discover new molecules that work together to remove unwanted DNA
September 21, 2018 - Dr. Fenella France to deliver 2019 Plenary Lecture
September 21, 2018 - New research finds that MHC-II molecules have more influence on tumors than MHC-I
September 21, 2018 - Researchers study effects of cardiac cycle in simple learning task
September 21, 2018 - FDA takes new steps to address opioid crisis by approving Opioid Analgesic Risk Evaluation and Mitigation Strategy
September 21, 2018 - Positive Barhemsys Phase 3 Treatment Data Published in Anesthesia & Analgesia
September 21, 2018 - Celiac Disease Screening: MedlinePlus Lab Test Information
September 21, 2018 - Autism linked to egg cells’ difficulty creating large proteins
September 21, 2018 - Tweaking nuclear pores could provide new avenue to battle against cancer
September 21, 2018 - Experts warn health care providers to slow down in allowing smart pill in patient care settings
September 21, 2018 - MoreGrasp reports breakthrough development of grasp neuroprosthetics activated by thought control
September 21, 2018 - Study reveals new way to target HER2-negative metastatic breast cancer
September 21, 2018 - CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL
September 21, 2018 - Study offers solid link between visceral organs and brain’s reward, motivation system
Producing Super-Swelled Lyotropic Crystals for Drug Development

Producing Super-Swelled Lyotropic Crystals for Drug Development

image_pdfDownload PDFimage_print

What are lyotropic liquid crystals? How are they used in drug development?

Liquid crystals are state of matter that have properties of liquids and crystals. There are several types of liquid crystal materials. There are some that change their properties as a response to temperature, called thermotropic liquid crystals, and others that change in response to a solvent. These are called lyotropic liquid crystals and in most cases the solvent is water.

Liposomes. Credit: RomanenkoAlexey/Shutterstock.com

Lyotropic liquid crystals are used in drug development because they are liquids, however, they do have some crystalline properties. There useful in drug development as they can be organized into structures that are ideal to encapsulate drugs and other bioactive molecules.

Lyotropic liquid crystals are used because they remain stable in water, which makes up a large percentage of the human body. Aqueous structures are essential for drug delivery in vivo, which is why lyotropic liquid crystals are so useful.

What methodologies have been used to produce lyotropic liquid crystals for drug development in the past?

Liposomes are the most used lyotropic liquid crystal for drug development. They are characterized by a membrane sphere with water and the target drug inside. The way drugs are developed using this method is complex.

You start with a lyotropic liquid crystal, which is a bilayer, or lamellar phase, that looks very much like sheets of a cell membrane. Then, you apply a technique to make little particles come out of the crystal. Following this, you add water and agitate the membrane. This causes the crystal to close-up into spheres with water on the inside; where the drug will go.

However, there are alternative methods. One example is bicontinuous cubic phases, which are three-dimensional objects that have lots of pores. The discovery of bicontinuous cubic phases got scientists thinking, “Well instead of just making liposomes, we can make other types of particles with other types of structures, and that might be beneficial”.

Due to their highly porous nature, these structures can, in theory, hold a larger amount of cargo than liposomes, making them superior structures for drug delivery. But to this day, liposomes are still the leading lyotropic liquid crystal used in drug delivery. This is because bicontinuous cubic phases are difficult to process and their pores are too small.

What are the limitations of the current methods used to produce lyotropic liquid crystals? Why is it important that new methods are developed?

Liposomes are great and very useful, but there are certain drugs that can crystallize inside them. If you have a method that uses a perforated membrane like bicontinuous cubic phases, larger, more complex drugs can be delivered, as the structure has an increased surface to volume ratio.

Another limitation of liposomes is that the drugs need to be soluble. This is a problem for hydrophobic drugs that won’t go into the water domain. They will want to go into the hydrophobic core of the membrane.

In liposomes you only have one membrane that encloses the drug. If you have other phases, like bicontinuous cubic phases, where the particle is made up of perforated membranes that allow the water to enter pores, you have a particle that is a continuum of water and fat everywhere.

If a liposome is, say, 200 nanometers, then those 200 nanometers are mostly made up of water. With bicontinuous cubic phases, you have tons of membranes that are continuous in both polar and hydrophobic domains. This means you can encapsulate drugs that are both water soluble and not water insoluble.

Then there are other advantages. For example, bicontinuous cubic phases are known to have a preferential interaction with cell membranes, allowing easier delivery of drugs into cells of the body.

Please outline your recent research involving lyotropic liquid crystals.

Traditionally, lyotropic liquid crystals had pores that are really small, only about three nanometers. So, there was a limit of what kind of drugs or proteins you could encapsulate within them. Our recent findings describe a new processing technique that allowed us to expand those pores to five times larger than previous methods, so they are now around 15 nanometers in size.

Dr. Cecilia Leal holding a 3D printed model of a super-swelled bicontinuous cubic phase monocrystal

Why are super-swelled lyotropic monocrystals such an advancement?

The first advancement was that we could make these materials with larger pores than ever before. The second was that the materials that we had generated were extremely stable for months. This is because, instead of existing as a collection of membranes, the liquid crystals had formed a monocrystal with extremely large pores.

Typically, if you do anything with membranes, or soft materials in general, you have these small unit cells or these small crystals or micro crystallites that appear. They are the size of a micron and are randomly oriented in all directions in solution.

We’ve found that if you let these highly porous membranes rest for a few months, they develop into a single crystal that is more than one cubic millimeter. It’s no longer micrometer size, its macro size; you can see it with the human eye.

What’s surprising to us is that, the crystal is still able to hold a lot of water. It’s 90% water, and is still soft but is also a crystalline shape like a diamond. That was very surprising to us. Not only that it is super swollen, but that it was also incredibly well-organized.

Whilst this might not be useful for drug development, it may be useful for protein crystallization. This has actually been used in a recent paper for Nature Communications. The researchers used our method to encapsulate the Gloeobacter ligand-gated ion channel protein (GLIC) when they crystallized it.

How did you find out that fast chloroform removal was crucial for producing lyotropic monocrystals?

If you want to develop a material using a mixture of liposomes or any form of lipid molecules, they first need to be solubilized in an organic solvent. The most commonly used solvent is chloroform, which is removed slowly and completely, creating the lyotropic liquid crystal. The addition of water turns the crystal into a liposome or bicontinuous cubic phase.

My student was working with some of these lipid mixtures, and was in a rush to move to the next step. This meant he removed the chloroform really fast. He then added the water and saw these super swollen phases develop.

He told me he’d messed up but when we looked, the solvent had been completely removed, so it was only the speed that differed, as it is usually done very slowly. He then started working on this method, comparing the size of the phases that develop from a slow, medium and fast speed of chloroform extraction.

He found that when you add water then the size of the pores that develop are a function of the speed at which the solvent is removed.  If you do this slowly you get the regular size, and if you do fast you get these super swollen phases.

We assumed it was a kinetic effect that wouldn’t be stable. But, it was stable, not thermodynamically, but it was stable. We let it sit for six months and found that not only was it still stable, it was actually more organized.  

In fact, liposomes are not thermodynamically stable either. They are formed via kinetic traps that are stable when you need to apply them but not thermodynamically, therefore this is not a limitation of our discovery. It’s been a year since we first discovered this method and our sample is still in the lab today.

What applications are there for super-swelled lyotropic monocrystals? What impact will the new methodology have on research?

I think the major applications of our research will be in protein crystallization. This is important because this is at the forefront of research, with the development of useful technologies such as Cryo-EM and imaging techniques to determine protein structure.

The leading technology to determine protein structure is crystallography. The limitations of current techniques are that most proteins are difficult to crystallize. Before our discovery, the number of proteins that you could crystallize was very limited. This was because the pores were so small that are only a handful of proteins could be crystallized.

In the future, do you think super-swelled lyotropic monocrystals will be routinely used in research and drug development?

Yes, I hope so. The good thing about the method is that it is a relatively easy processing technique, meaning it is accessible to many scientists. It is also a reliable technique as the materials themselves are highly flexible. For example, let’s say you want to use a cocktail of three different lipids that target a specific cell type, with this method, you could use any lipid as long as you removed the solvent fast.

I think that it will have a big impact. However, the widespread use of new techniques take time. People are very used to working with liposomes and they are more familiar than other more complicated structures.

Where can readers find more information?

  • Dr. Cecilia Leal’s profile for The University of Illinois
  • The Leal Research group
  • Zabara, A., Chong, J., Martiel, I., Stark, L., Cromer, B., Speziale, C., Drummond, C. and Mezzenga, R. (2018). Design of ultra-swollen lipidic mesophases for the crystallization of membrane proteins with large extracellular domains. Nature Communications.

About Dr. Cecília Leal

Cecília Leal is an Assistant Professor in the Department of Materials Science and Engineering and the Frederick Seitz Materials Research Laboratory at the University of Illinois, Urbana-Champaign. She graduated in Industrial Chemistry from Coimbra University in Portugal before moving to Sweden to do a PhD in physical chemistry at Lund University, supervised by Professor Wennerström.

After working for a year in the Norwegian Radium Hospital, she joined Professor Safinya’s Lab at the University of California, Santa Barbara, as a postdoctoral fellow.

Her research interests focus on the characterization and functionalization of lipid materials for cellular delivery. She is the recipient of the National Institutes of Health New Innovator award (2016), the National Science Foundation CAREER award (2016), and the University of Illinois Dean’s Award of Excellence in Research (2018).

Tagged with:

About author

Related Articles